Mectizan, containing the active ingredient ivermectin, is an anti-parasitic medication used to treat several neglected tropical diseases. It is a semisynthetic derivative of a family of compounds produced by the soil bacterium Streptomyces avermitilis.
Uses
The main uses of Mectizan include:
- Treatment of onchocerciasis (river blindness)
- Treatment of strongyloidiasis
- Treatment of scabies
- Control programs to eliminate lymphatic filariasis
- Potential role in treating other parasitic worm infections
Benefits
Key benefits of taking Mectizan include:
- Effectively treats and prevents onchocerciasis, a leading cause of preventable blindness
- Rapidly eliminates scabies infestation
- Broad-spectrum anti-parasitic activity against several worm infections
- Well-tolerated with minimal adverse effects when used properly
- Effectively eliminates parasitic worms and larvae
- Provides single-dose treatment for many conditions
- Reduces symptoms of parasitic infections quickly
- Prevents transmission of certain parasitic diseases
- Well-tolerated with minimal side effects
- Cost-effective treatment option
- Suitable for mass treatment programs
- Improves quality of life in infected patients
- Helps prevent blindness from onchocerciasis
How It Works
Mectizan binds to glutamate-gated chloride channels in parasite nerve and muscle cells, causing paralysis and death. It disrupts the parasite’s nervous system while having minimal effect on mammals due to different receptor locations. This selective toxicity makes it highly effective against target parasites.
Dosage
| Age Group | Standard Dosage | Conditions Treated |
|---|---|---|
| 1–4 years | 1/2 tablet (1.5mg) Not routinely recommended unless under strict medical supervision | Onchocerciasis (River Blindness), Strongyloidiasis (in selected cases) |
| 5–11 years | 1 tablet (3 mg) once | Onchocerciasis, Strongyloidiasis, Scabies |
| 12–17 years | 2 tablets (6 mg) once | Onchocerciasis, Strongyloidiasis, Scabies, Lice |
| 18–64 years | 3–4 tablets (9–12 mg) once | Onchocerciasis, Strongyloidiasis, Scabies, Lice |
| 65 years and above | 3–4 tablets (9–12 mg) once (monitor closely) | Onchocerciasis, Strongyloidiasis, Scabies, Lice |
Take Mectizan on empty stomach with water. Single dose is usually sufficient, repeat after 3-12 months if necessary.
Duration of Action
Mectizan begins working within hours of administration, with peak blood levels reached in 4 hours. Parasite death occurs within 24-48 hours. Clinical improvement is typically seen within 1-2 weeks. The medication remains active for several weeks, providing prolonged protection against reinfection.
Side Effects
Most patients experience mild or no side effects. Common reactions include dizziness, nausea, and mild skin irritation. In areas with high parasite loads, temporary worsening of symptoms may occur due to dying parasites. Serious side effects are rare but may include severe skin reactions.
Warning
Not recommended for children under 1 year or weighing less than 15kg. Mectizan may cause severe reactions in patients with high Loa loa microfilarial loads. Avoid in pregnancy unless benefits clearly outweigh risks. Do not use in patients with known hypersensitivity to ivermectin.
Pregnancy and Breastfeeding
Mectizan should be avoided during pregnancy unless absolutely necessary for life-threatening infections. Limited data suggests low risk to developing fetus. Ivermectin passes into breast milk in small amounts. Breastfeeding mothers should consult healthcare providers before taking Mectizan.
Interaction
- May increase effects of warfarin and other blood thinners
- Possible interaction with certain seizure medications
- May enhance effects of other antiparasitic drugs
- Alcohol may increase risk of central nervous system side effects
- Limited interactions with most common medications
Precaution
Use cautiously in patients with liver disease, CNS disorders, or compromised immune systems. Monitor elderly patients closely for adverse reactions. Ensure proper diagnosis before treatment. In endemic areas, consider community-wide treatment programs. Avoid driving immediately after taking due to potential dizziness.
Important Information
Mectizan should only be used under medical supervision with confirmed parasitic infection diagnosis. Complete any recommended follow-up testing to ensure treatment effectiveness. Store at room temperature away from moisture and heat. This medication may be part of community-wide treatment programs in endemic areas to prevent disease transmission.
It is worth noting that there has been some controversy around the use of Mectizan for COVID-19 treatment, as some people have claimed that it can be effective in treating the disease.
Reviews
There are no reviews yet.